Employee Reservation Portion aggregating up to Rs15 million, discount of Rs76 per Equity Share being offered to Eligible Employees
FinTech BizNews Service
August 5, 2026: Molbio Diagnostics Limited (the “Company”) proposes to open an initial public offering of its equity shares of face value of Rs1 each (“Equity Shares” and such offering the “Offer”) on Monday, August 10, 2026. The Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, being Friday, August 7, 2026. The Bid/ Offer Closing Date is Wednesday, August 12, 2026*.
UPI mandate end time and date shall be at 5:00 pm on the Bid/Offer Closing Date.
Red Herring Prospectus dated August 3, 2026 (“RHP”) link – https://www.molbiodiagnostics.com/wp-content/uploads/2026/08/Molbio-Diagnostics-Limited-Red-Herring-Prospectus.pdf
The Price Band of the Offer has been fixed from Rs 768 per Equity Share of face value Rs1 each to Rs 807 per Equity Share of face value Rs1 each. Bids can be made for a minimum of 18 Equity Shares of face value Rs1 each and multiples of 18 Equity Shares of face value Rs1 each thereafter.
L to R: Mr. Sriram Natarajan, Executive Director & Chief Executive Officer, Molbio Diagnostics Limited and Dr. Chandrasekhar Nair, Executive Director & Chief Technology Officer, Molbio Diagnostics Limited at the press conference to announce the IPO.
The Offer comprises of a Fresh Issue of Equity Shares aggregating up to Rs2,000.00 million and an Offer for Sale of up to 91,66,000 Equity Shares by the Selling Shareholders.
The Offer for Sale includes up to 1,811,000 Equity Shares aggregating up to Rs [●] million by Exxora Trading LLP (Promoter Selling Shareholder); up to 1,221,000 Equity Shares aggregating up to Rs [●] million by Dr. Chandrasekhar Bhaskaran Nair (Promoter Selling Shareholder); up to 1,000,000 Equity Shares aggregating up to Rs [●] million by India Business Excellence Fund III (Investor Selling Shareholder); and following Other Selling Shareholders - up to 1,125,000 Equity Shares aggregating up to Rs [●] million by Gopalkrishna Mangalore Kini; up to 902,000 Equity Shares aggregating up to Rs [●] million by J. Guru Dutt; up to 902,000 Equity Shares aggregating up to Rs [●] million by Gopalakrishna Sampathgiri; up to 452,000 Equity Shares aggregating up to Rs [●] million by Sangeetha M Kini; up to 451,000 Equity Shares aggregating up to Rs [●] million by M.A. Usha Rani; up to 248,000 Equity Shares aggregating up to Rs [●] million by M.A. Rohit; up to 226,000 Equity Shares aggregating up to Rs [●] million by Shruthi G Kini; up to 202,000 Equity Shares aggregating up to Rs [●] million by M.A. Sharath; up to 193,000 Equity Shares aggregating up to Rs [●] million by Chewbacca Services Limited; up to 193,000 Equity Shares aggregating up to Rs [●] million by Sujay Limited; up to 97,000 Equity Shares aggregating up to Rs [●] million by Shaheeda Abdul Kader; up to 78,000 Equity Shares aggregating up to Rs [●] million by Vivek Devaraj; up to 48,000 Equity Shares aggregating up to Rs [●] million by Abdul Qadir Mohamed Theruvath and up to 17,000 Equity Shares aggregating up to Rs [●] million by M Ganesh Kamath (collectively “Selling Shareholders”).
Further, Equity Shares will be allocated on a proportionate basis to Eligible Employees applying under the Employee Reservation Portion, subject to valid Bids received from them at or above the Offer Price.
The Equity Shares of the Company are proposed to be listed on BSE Limited (“BSE") and the National Stock Exchange of India Limited (“NSE”) (BSE and NSE together, the “Stock Exchanges”).
Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited and Motilal Oswal Investment Advisors Limited are the Book Running Lead Managers (“BRLMs”) to the Offer.
